Related Experiment Videos
Chondro-perichondrial connection in middle ear surgery
F Olaizola1, H Ballivian, J Horna
1Pabellon n. Ciudad Universitaria, Madrid, Spain.
Revue De Laryngologie - Otologie - Rhinologie
|January 1, 1995
Summary
This study highlights the success of using autologous cartilage and perichondrium grafts in tympanoplasty. These "butterfly" grafts show promising tympanoplastic and hearing gain results, offering a safe alternative to synthetic materials.
Area of Science:
- Otolaryngology
- Regenerative Medicine
- Biomaterials in Surgery
Background:
- Tympanoplasty aims to restore hearing and conserve the ear.
- Challenges in obtaining organic tissues due to HIV risk have increased interest in synthetic alternatives.
- Autologous tissues offer a biocompatible option for reconstructive surgery.
Purpose of the Study:
- To evaluate the efficacy of a novel autologous cartilage and perichondrium graft, termed "butterfly", in tympanoplasty.
- To assess both the tympanoplastic (structural repair) and functional (hearing gain) outcomes of this surgical technique.
Main Methods:
- A prospective study involving 50 patients undergoing tympanoplasty using the "butterfly" graft.
- The graft was constructed from the patient's own cartilage and perichondrium.
- Tympanoplastic success was evaluated 18 months post-surgery, and functional hearing results were assessed 3 years post-surgery.
Main Results:
- Excellent tympanoplastic results: 86% good outcomes, 0% perforations, and resolution of aural discharges in 12% of cases.
- Significant functional hearing improvement: 72% of patients achieved a hearing gain of over 15 dB.
- Overall positive outcomes with minimal complications, demonstrating the viability of autologous grafts.
Conclusions:
- Autologous cartilage and perichondrium "butterfly" grafts provide a safe and effective option for tympanoplasty.
- This technique yields high rates of successful tympanic membrane reconstruction and meaningful hearing improvement.
- The use of autologous tissue circumvents risks associated with homografts and donor site morbidity.